nach oben

Erschienen in:

01.06.2013 | Women and Heart Disease (J Robinson, Section Editor)

Women and Heart Failure: An Emerging Venus-Mars Concept

Erschienen in: Current Cardiovascular Risk Reports | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Some of the most profound sex differences in cardiovascular disease are evident in the syndrome of heart failure. Certain heart failure conditions have a unique predilection for women, such as heart failure with preserved ejection fraction and apical ballooning syndrome; or are exclusive to women, such as peripartum cardiomyopathy. Overall, there are notable differences between women and men in terms heart failure disease burden, risk factors, clinical presentation and prognosis. Yet, women remain under-represented in heart failure clinical trials. Important knowledge gaps exist in our understanding of the pathophysiologic basis for these sex differences and potential for effective sex-specific management strategies.

Velagaleti RS, Gona P, Larson MG, et al. Multimarker approach for the prediction of heart failure incidence in the community. Circulation. 2010;122:1700–6.PubMedCrossRef

Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics−−2012 Update: a report from the American Heart Association. Circulation. 2012;125:e2–220.PubMedCrossRef

Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–2594.PubMedCrossRef

Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123:2006–14.PubMedCrossRef

Hsich EM, Pina IL. Heart failure in women: A need for prospective data. J Am Coll Cardiol. 2009;54:491–8.PubMedCrossRef

Rho RW, Patton KK, Poole JE, et al. Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation. 2012;126:2402–7.PubMedCrossRef

•• Martinez-Selles M, Doughty RN, Poppe K, et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012;14:473–9. This meta-analysis represents the largest assessment of the association of sex and heart failure survival rates.PubMedCrossRef

Hsich EM, Grau-Sepulveda MV, Hernandez AF, et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J. 2012;163(3):430–7.PubMedCrossRef

•• Scantlebury DC, Borlaug BA. Why women are more likely then men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol. 2011;26:562–8. Why women are more likely then men to develop heart failure with preserved ejection fraction?.PubMedCrossRef

10.

Fujimoto N, Borlaug BA, Lewis GD, et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation. 2013;127(1):55–62.PubMedCrossRef

11.

Piro M, Della Bona R, Abbate A, et al. Sex-related differences in myocardial remodeling. J Am Coll Cardiol. 2010;55:1057–65.PubMedCrossRef

12.

Petrov G, Regitz-Zagrosek V, Lehmkuhl E, et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation. 2010;122(11 Suppl):S23–8.PubMedCrossRef

13.

De Simone G, Devereux RB, Chinali M, et al. Sex differences in obesity related changes in left ventricular morphology: the strong heart study. J Hypertens. 2011;29:1431–8.PubMedCrossRef

14.

Rossi P, Frances Y, Kingwell BA, et al. Gender differences in artery wall biomechanical properties throughout life. J Hypertens. 2011;29:1023–33.PubMedCrossRef

15.

Borlaug BA. Sex, load and relaxation; are women more susceptible to load-dependent diastolic dysfunction? J Am Coll Cardiol. 2011;57:1234–6.PubMedCrossRef

16.

•• Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32(6):670–9. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.PubMedCrossRef

17.

• Lam CS, Donal E, Kraigher-Krainer E, et al. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18–28. This article gives a comprehensive review of the current epidemiology trends and clinical course and disease outcomes of HFpEF.PubMedCrossRef

18.

Melander O, Maisel AS, Almgren P, et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA. 2012;308(14):1469–75.PubMedCrossRef

19.

• Lam CS, Carson PE, Anand IS, et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the i-preserve trial. Circ Heart Fail. 2012;5(5):571–8. This article represents the largest and most representative study of HFpEF with a sex-specific analysis and outcomes.PubMedCrossRef

20.

Looi JL, Wong CW, Khan A, et al. Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New Zealand. Heart Lung Circ. 2012;21(3):143.PubMedCrossRef

21.

Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012;164(2):215–21.PubMedCrossRef

22.

• Eitel I, von Knobelsdorff-Brekenhoff F, Bernhardt P, et al. Clinical characteristics and CV magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA. 2011;306:277–86. This article describes the clinical characteristics of ABS is a large multicenter cohort, and has the largest magnetic resonance imaging series of ABS to date.PubMedCrossRef

23.

Maron BJ, Towbin JA, Thiene G, et al. American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16.PubMedCrossRef

24.

Deshmukh A, Kumar G, Pant S, et al. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J. 2012;164(1):66–71.PubMedCrossRef

25.

Cacciotti L, Passaseo I, Marazzi G, et al. Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up. BMJ Open. 2012;2:e001165.PubMedCrossRef

26.

• Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–70. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management.PubMedCrossRef

27.

Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.PubMedCrossRef

28.

Burlingame J, Horiuchi B, Ohana P, et al. The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system. J Perinatol. 2012;32(3):163–9.PubMedCrossRef

29.

Biteker M, Ilhan E, Biteker G, et al. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J of Heart Fail. 2012;14(8):895–901.CrossRef

30.

Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17(5):426–30.PubMedCrossRef

31.

Biteker M, Duran NE, Kaya H, et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol. 2011;100:571–7.PubMedCrossRef

32.

Gevaert S, Van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and ‘bridge to’ therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15:R93.PubMedCrossRef

33.

Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465–73.PubMedCrossRef

34.

Ballo P, Betti I, Mangialavori G, et al. Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine. Case Rep Med. 2012;2012:476903.PubMed

35.

Safirstein JG, Ro AS, Grandhi S, et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31.PubMedCrossRef

36.

Mandal D, Mandal S, Mukherjee D, et al. Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res. 2011;37:222–7.PubMedCrossRef

37.

Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87:34–9.PubMedCrossRef

Titel: Women and Heart Failure: An Emerging Venus-Mars Concept
Publikationsdatum: 01.06.2013
Erschienen in: Current Cardiovascular Risk Reports / Ausgabe 3/2013
Print ISSN: 1932-9520
Elektronische ISSN: 1932-9563
DOI: https://doi.org/10.1007/s12170-013-0307-z

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Women and Heart Failure: An Emerging Venus-Mars Concept

Abstract

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Pregnancy Complications and the Risk of Metabolic Syndrome for the Offspring

Predicting Women’s Future Cardiovascular Health from Pregnancy Complications

Cardiac Rehabilitation for Women

Cardiovascular Risks of Hormonal Contraceptives

Women’s Health Initiative Hormone Therapy Trials: New Insights on Cardiovascular Disease from Additional Years of Follow up

Type 2 Diabetes in Older People; The Importance of Blood Pressure Control

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie